Up to 50% of menopausal women experience urinary incontinence, with symptoms evolving from stress to urgency and mixed types over time. Estrogen deficiency and genitourinary changes contribute significantly, impacting quality of life and often remaining underdiagnosed.
Menopause and gastrointestinal health and disease - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40410564/
Menopause has far-reaching effects on human physiology, including the gastrointestinal tract, and can negatively influence the quality of life of women who are affected. Menopause can have multiple effects on...
Review examines effects of menopause on gastrointestinal health, including altered motility, microbiota changes, increased disease risk, and implications of hormone therapy on symptoms and overall quality of life.
Network analysis of patient-reported complaints in climacteric syndrome: a single-center study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/41935990/
By analyzing medical records of patients with climacteric syndrome, this study clarified symptom patterns in menopausal women, providing data for targeted and stage-specific treatments.
Network analysis identifies pain and hot flushes as central symptoms in climacteric syndrome, with interconnected fatigue and sleep disturbances, highlighting opportunities for targeted, stage-specific management in menopausal women.
Did you know? Menopause may amplify the impact of environmental exposures on health. Emerging evidence shows heavy metals can disrupt the oral microbiome, with postmenopausal women exhibiting loss of key microbial species and altered metabolic pathways linked to cardiovascular and metabolic risk.
Could targeting environmental exposures and microbiome health offer new strategies to reduce systemic risks in postmenopausal women?

Could targeting environmental exposures and microbiome health offer new strategies to reduce systemic risks in postmenopausal women?
Beyond recurrence detection: Treating the forgotten menopause in endometrial cancer survivors - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/41904920/
Endometrial cancer is the most curable gynecological malignancy. Recurrence detection remains central to follow-up; however the management of treatment-induced morbidity remains comparatively underemphasized. As a result, menopausal symptoms remain under-recognized,...
Menopausal symptoms in endometrial cancer survivors remain underrecognized, despite evidence supporting safe hormone therapy in early-stage disease, highlighting the need for personalized, multidisciplinary survivorship care prioritizing quality of life.

